InvestorsHub Logo

PG

Followers 105
Posts 871
Boards Moderated 0
Alias Born 03/27/2013

PG

Re: None

Thursday, 08/01/2013 9:00:56 AM

Thursday, August 01, 2013 9:00:56 AM

Post# of 158400
My thought for the day:

Regen has already filed one non-provisional patent application and is preparing to file two more based on research conducted in support of Its IND application.



Safety has been proved. Efficacy has been proved by way of the information generated and submitted to the FDA. The PR clearly states the efficacy data has been generated. Again, they have generated the requested data. NOT are generating. It is DONE.

You do not file additional applications that are derived from a treatment that is denied or appears will be denied by the FDA. THAT DOESN'T HAPPEN

Every indicator--from the science/data to the above mentioned quote from yesterdays PR--clearly shows that in the very near future HemaXellerate WILL be successful in human trials and, because it will be deemed an Orphan Drug by the FDA, will soon be marketed. Following suit will be at least two more patented treatments.

All the while, the Min Science will be setting itself up to take the world of cancer treatment by storm.

GO BMSN! Go, GO, GO!

Socialism is a philosophy of failure, the creed of ignorance, and the gospel of envy, its inherent virtue is the equal sharing of misery. --Winston Churchil

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.